These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 24576935)

  • 1. [Treatment goals of osteoporosis].
    Hosoi T
    Clin Calcium; 2014 Mar; 24(3):385-9. PubMed ID: 24576935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Daily practice using the guidelines for prevention and treatment of osteoporosis. Utilization of metabolic markers of bone in daily osteoporosis practice].
    Miki T; Masaki H
    Clin Calcium; 2008 Aug; 18(8):1127-34. PubMed ID: 18677050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Measurement of bone mineral density is unnecessary for monitoring of bisphosphonate treatment].
    Nishida A; Ito M
    Clin Calcium; 2011 Jan; 21(1):120-3. PubMed ID: 21187605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-osteoporosis drugs based on the guidelines for the Prevention and Treatment of Osteoporosis (2011 edition) ].
    Ono K; Ohashi S; Tanaka S
    Clin Calcium; 2014 Mar; 24(3):401-6. PubMed ID: 24576937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New development in bisphosphonate treatment. Fracture prevention by bisphosphonates].
    Hosoi T
    Clin Calcium; 2009 Jan; 19(1):11-8. PubMed ID: 19122260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New development in bisphosphonate treatment. Review of effect on bone metabolism by minodronic acid in primary osteoporosis].
    Fukunaga M
    Clin Calcium; 2009 Jan; 19(1):63-73. PubMed ID: 19122266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Measurement of bone mineral density is necessary for monitoring of bisphosphonate treatment].
    Soen S
    Clin Calcium; 2011 Jan; 21(1):116-9. PubMed ID: 21187604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairments precede fractures.
    Schute LL
    Dtsch Arztebl Int; 2009 Jan; 106(3):38; author reply 39-40. PubMed ID: 19564963
    [No Abstract]   [Full Text] [Related]  

  • 9. [Criteria for initiation of pharmacological treatment by Japanese 2011 guidelines for prevention and treatment of osteoporosis].
    Hagino H
    Clin Calcium; 2014 Mar; 24(3):339-47. PubMed ID: 24576930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Diagnosis and Treatment of Osteoporosis].
    Kageyama G
    Rinsho Byori; 2015 May; 63(5):570-9. PubMed ID: 26524896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Living with a dilemma.
    Hörr B
    Dtsch Arztebl Int; 2009 Jan; 106(3):38-9; author reply 39-40. PubMed ID: 19564961
    [No Abstract]   [Full Text] [Related]  

  • 12. [Biochemical markers of bone turnover. New aspect. Biochemical markers of bone turnover in long term treatment with bisphosphonate].
    Asano S; Suzuki A; Itoh M
    Clin Calcium; 2009 Aug; 19(8):1179-85. PubMed ID: 19638702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study finds no link between bone drugs and unusual thigh fractures.
    Harv Womens Health Watch; 2010 Jul; 17(11):6. PubMed ID: 20684079
    [No Abstract]   [Full Text] [Related]  

  • 14. [New development in bisphosphonate treatment. When and how long should patients take bisphosphonates for osteoporosis?].
    Yamaguchi T; Sugimoto T
    Clin Calcium; 2009 Jan; 19(1):38-43. PubMed ID: 19122263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Outline of Guidelines 2004 for bone marker in osteoporosis].
    Nishizawa Y
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():37-41. PubMed ID: 18161079
    [No Abstract]   [Full Text] [Related]  

  • 16. Duration of treatment for osteoporosis.
    Idolazzi L; Fassio A; Gatti D; Tamanini S; Viapiana O; Rossini M; Adami S
    Reumatismo; 2013 Mar; 65(1):22-35. PubMed ID: 23550257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Better informed decisions in the management of osteoporosis].
    Alonso-Coello P; Bonfill X
    Reumatol Clin; 2011; 7(1):1-2. PubMed ID: 21794771
    [No Abstract]   [Full Text] [Related]  

  • 18. [Daily practice using the guidelines for prevention and treatment of osteoporosis. Evolution of bisphosphonate therapy. Intravenous injection].
    Hagino H; Hashimoto J; Okano T; Katagiri H
    Clin Calcium; 2008 Aug; 18(8):1176-82. PubMed ID: 18677057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alendronate for treatment of osteoporoses].
    Harada A
    Nihon Rinsho; 2009 May; 67(5):943-7. PubMed ID: 19432114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonate-induced fractures: nature strikes back?
    Aspenberg P
    Acta Orthop; 2008 Aug; 79(4):459-60. PubMed ID: 18766476
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.